Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Yooyoung Pharmaceutical Co., Ltd.
Age
30–75
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Male and Female aged between 30 and 75 years, inclusive
Subjects who want improvement of nasolabial folds that are rated as grade 3 or 4 on Wrinkle severity rating scale(WSRS)
Subjects who have visually symmetrical bilateral nasolabial folds
Subjects who consent to discontinue all dermatological treatment or cure including wrinkle correction in and around infraorbital region during this trial
Subjects who voluntarily decide to participate in this trial and provide written consent in the Informed Consent Form
You may not be if
Subject who have bleeding disorder in the past or present
Other criteria as identified in the protocol
Clareo Health | Clinical Trial of YYD701-2 for Treatment of Nasolabial Folds
